Treatment of Influenza (Flu)
The recommended first-line treatment for influenza is oseltamivir (Tamiflu) 75 mg twice daily for 5 days in adults, with treatment ideally initiated within 48 hours of symptom onset. 1
Antiviral Medication Options
Oseltamivir (Tamiflu)
- First-line treatment for both influenza A and B
- Dosing for adults: 75 mg twice daily for 5 days 2
- Pediatric dosing (weight-based) 1, 2:
- ≤15 kg: 30 mg twice daily
- 15.1-23 kg: 45 mg twice daily
- 23.1-40 kg: 60 mg twice daily
40 kg: 75 mg twice daily
- Can be taken with food to enhance tolerability 2
- Reduces illness duration by approximately 24 hours when started within 48 hours 3, 4
Alternative Antivirals
- Zanamivir (Relenza): 10 mg (two 5-mg inhalations) twice daily for 5 days 5
- For patients ≥7 years without underlying respiratory disease
- Administered via oral inhalation only
- Not recommended for patients with underlying respiratory conditions due to risk of bronchospasm
Treatment Algorithm
Initiate treatment as soon as possible:
Patient assessment for treatment:
Treat all patients with:
Consider treatment for:
- Otherwise healthy patients with uncomplicated influenza if within 48 hours of symptom onset 6
Treatment duration:
Supportive Care
- Fever management with antipyretics (avoid aspirin in children) 1
- Adequate hydration and rest 1
- Monitor for worsening symptoms that may indicate complications 6
Antibiotic Use
- Antibiotics are not routinely indicated for uncomplicated influenza or acute bronchitis complicating influenza 6
- Consider antibiotics only for:
Special Considerations
- Patients unable to mount a febrile response (immunocompromised, elderly) may still benefit from antiviral treatment despite lack of documented fever 6
- Hospitalized patients may benefit from antiviral treatment even if started >48 hours from symptom onset 6
- Adjust oseltamivir dosage in patients with renal impairment 2
Common Pitfalls to Avoid
- Delaying treatment while waiting for laboratory confirmation - treatment decisions should be made clinically during influenza season 1
- Unnecessary antibiotic use - reserve for suspected bacterial complications 6, 1
- Missing treatment windows - greatest benefit occurs when treatment is started within 48 hours, but later treatment can still be beneficial in severe cases 6
- Overlooking high-risk patients who may not present with typical symptoms, especially the elderly or immunocompromised 6
The evidence consistently shows that early antiviral treatment reduces the duration of influenza symptoms by approximately 24 hours in otherwise healthy patients 3, 4, 7 and may reduce the risk of serious complications, particularly in high-risk populations.